Final report of Radiation Therapy Oncology Group (RTOG) protocol 9802: Radiation therapy (RT) versus RT+ procarbazine, CCNU, and vincristine (PCV) chemotherapy for adult low-grade glioma (LGG)

被引：19
|
作者：
Shaw, E. G.
Wang, M.
Coons, S.
Brachman, D.
Buckner, J. C.
Stelzer, K.
Barger, G.
Brown, P. D.
Gilbert, M. R.
Mehta, M. P.
机构：
[1] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA
[2] Radiat Therapy Oncol Grp, Philadelphia, PA USA
[3] Barrow Neurol Inst, Phoenix, AZ 85013 USA
[4] Arizona Oncol Serv Fdn, Phoenix, AZ USA
[5] Mayo Clin, Rochester, MN USA
[6] Celilo Canc Ctr, The Dalles, WA USA
[7] Wayne State Univ, Sch Med, Detroit, MI USA
[8] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[9] Univ Wisconsin, Sch Med, Madison, WI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.2006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2006
引用
收藏
页数：1
相关论文
共 30 条
  • [1] RADIATION THERAPY (RT) VERSUS RT plus PROCARBAZINE, CCNU, AND VINCRISTINE (PCV) CHEMOTHERAPY FOR ADULT LOW-GRADE GLIOMA (LGG): RADIATION THERAPY ONCOLOGY GROUP (RTOG) PROTOCOL 9802
    Shaw, Edward
    Wang, Meihua
    Coons, Stephen W.
    Brachman, David
    Buckner, Lan
    Stelzer, Keith
    Barger, Gcoffrey
    Brown, Paul
    Gilbert, Mark R.
    Mehta, Minesh
    NEURO-ONCOLOGY, 2008, 10 (05) : 884 - 885
  • [2] Radiation therapy oncology group (RTOG) protocol 9802: Radiation therapy (RT) alone versus RT plus PCV chemotherapy in adult lowgrade glioma (LGG)
    Shaw, E. G.
    Berkey, B.
    Coons, S. W.
    Brachman, D.
    Buckner, J. C.
    Stelzer, K. J.
    Barger, G. R.
    Brown, P. D.
    Gilbert, M. R.
    Mehta, M.
    NEURO-ONCOLOGY, 2006, 8 (04) : 489 - 490
  • [3] Phase III study of radiation therapy (RT) with or without procarbazine, CCNU, and vincristine (PCV) in low-grade glioma: RTOG 9802 with Alliance, ECOG, and SWOG
    Buckner, Jan C.
    Pugh, Stephanie L.
    Shaw, Edward G.
    Gilbert, Mark R.
    Barger, Geoffrey
    Coons, Stephen
    Ricci, Peter
    Bullard, Dennis
    Brown, Paul D.
    Stelzer, Keith
    Brachman, David
    Suh, John H.
    Schultz, Christopher J.
    Bahary, Jean-Paul
    Fisher, Barbara Jean
    Kim, Harold
    Murtha, Albert D.
    Curran, Walter J.
    Mehta, Minesh P.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [4] Mature Survival Data from RTOG 9802: A Phase III Study of Radiation Therapy (RT) With or Without Procarbazine, CCNU, and Vincristine (PCV) for Adult Patients with High-Risk Low-Grade Glioma (LGG)
    Mehta, M. P.
    Won, M.
    Shaw, E. G.
    Buckner, J.
    Gilbert, M.
    Barger, G.
    Coons, S.
    Ricci, P.
    Bullard, D.
    Brown, P. D.
    Stelzer, K.
    Brachman, D. G.
    Suh, J. H.
    Schultz, C.
    Bahary, J.
    Fisher, B. J.
    Kim, H.
    Murtha, A. D.
    Curran, W. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S37 - S38
  • [5] Initial report of Radiation Therapy Oncology Group (RTOG) 9802: Prospective studies in adult low-grade glioma (LGG).
    Shaw, E. G.
    Berkey, B.
    Coons, S. W.
    Brachman, D.
    Buckner, J. C.
    Stelzer, K. J.
    Barger, G. R.
    Brown, P. D.
    Gilbert, M. R.
    Mehta, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 58S - 58S
  • [6] R9802: PHASE III STUDY OF RADIATION THERAPY (RT) WITH OR WITHOUT PROCARBAZINE, CCNU, AND VINCRISTINE (PCV) IN LOW-GRADE QLIOMA: RESULTS BY HISTOLOGIC TYPE
    Buckner, Jan
    Shaw, Edward
    Pugh, Stephanie
    Gilbert, Mark
    Barger, Geoffrey
    Coons, Stephen
    Ricci, Peter
    Bullard, Dennis
    Brown, Paul
    Stelzer, Keith
    Brachman, David
    Suh, John
    Schultz, Christopher
    Bahary, Jean-Paul
    Fisher, Barbara
    Kim, Harold
    Murtha, Albert
    Won, Minhee
    Mehta, Minesh
    Curran, Walter, Jr.
    NEURO-ONCOLOGY, 2014, 16
  • [7] Randomized Trial of Radiation Therapy Plus Procarbazine, Lomustine, and Vincristine Chemotherapy for Supratentorial Adult Low-Grade Glioma: Initial Results of RTOG 9802
    Shaw, Edward G.
    Wang, Meihua
    Coons, Stephen W.
    Brachman, David G.
    Buckner, Jan C.
    Stelzer, Keith J.
    Barger, Geoffrey R.
    Brown, Paul D.
    Gilbert, Mark R.
    Mehta, Minesh P.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (25) : 3065 - 3070
  • [8] Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma
    Bell, Erica H.
    Zhang, Peixin
    Shaw, Edward G.
    Buckner, Jan C.
    Barger, Geoffrey R.
    Bullard, Dennis E.
    Mehta, Minesh P.
    Gilbert, Mark R.
    Brown, Paul D.
    Stelzer, Keith J.
    McElroy, Joseph P.
    Fleming, Jessica I.
    Timmers, Cynthia D.
    Becker, Aline P.
    Salavaggione, Andrea L.
    Liu, Ziyan
    Aldape, Kenneth
    Brachman, David G.
    Gertler, Stanley Z.
    Murtha, Albert D.
    Schultz, Christopher J.
    Johnson, David
    Laack, Nadia N.
    Hunter, Grant K.
    Crocker, Ian R.
    Won, Minhee
    Chakravarti, Arnab
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (29) : 3407 - 3417
  • [9] Radiation therapy (RT) alone vs intensive procarbazine-CCNU-vincristine (I-PCV) chemotherapy followed by radiation therapy for anaplastic oligodendroglioma (AO) and mixed oligo-astrocytoma (MOA): Results of radiation therapy oncology group (RTOG) - Intergroup protocol 94-02
    Shaw, EG
    Seiferheld, W
    Cairncross, JG
    Jenkins, R
    Scheithauer, B
    Brachman, D
    Buckner, J
    Fink, K
    Souhami, L
    Curran, W
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S163 - S163
  • [10] Radiation Therapy Oncology Group 9802: Controversy or Consensus in the Treatment of Newly Diagnosed Low-Grade Glioma?
    Laack, Nadia N.
    Sarkaria, Jann N.
    Buckner, Jan C.
    SEMINARS IN RADIATION ONCOLOGY, 2015, 25 (03) : 197 - 202
123